Trial Profile

A Double-Blind, Multicenter, Randomized, Placebo-Controlled Trial Of The Efficacy Of Diclectin For Nausea And Vomiting Of Pregnancy.

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 10 Nov 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Doxylamine/pyridoxine (Primary)
Indications Morning sickness; Nausea and vomiting
Focus Registrational; Therapeutic Use

Most Recent Events

10 Apr 2019 According to an Alliance Pharma plc media release, Xonvea has been approved in Ireland.
10 Apr 2013 Doxylamine/pyridoxine is approved in the US based on the results of this trial according to a Duchesnay media release.
16 Sep 2010 Results published in the American Journal of Obstetrics and Gynecology, reported in a Duchesnay Inc. media release.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com